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OBJECTIVES: To compare discrete event simulation (DES)
models with Markov models for simulating patient ﬂows in an
intensive care unit (ICU). METHODS: We developed a Markov
model and a DES model to simulate the patient ﬂow in an ICU
with a focus on mechanical ventilation (MV) on the basis of the
Dutch UltiSAFE trial. In UltiSAFE, different sedation regimens
(remifentanil-based sedation vs. conventional sedation) in criti-
cally ill patients requiring mechanical ventilation were investi-
gated. We deﬁned 8 states in the models: MV—maintenance,
MV—eligible for weaning, MV—actual weaning, MV—eligible
for extubation, ICU—extubated, ICU—eligible for discharge,
Discharged from ICU, and Dead. Patients move through states 1
to 7 in sequence, unless they die. In the Markov model, a time
cycle of 1 hour was applied. We compared the models with
respect to results (length of stay in each phase), ease of scenario
analysis, stability of results and computation time. RESULTS:
The results of both models were very similar. However, differ-
ences were found for all times between the eligible and actual
event, due to the fact that this time was 0 for around 30% of
patients. The Markov model requires a patient to stay in a state
for at least the cycle length (1 hour), whereas DES allows instan-
taneous transitions. The DES model enabled rapid post-hoc sub-
group analysis whereas multiple runs of the Markov model were
required for this type of analysis. Results were more stable in the
Markov model than in the DES model. The computation for both
the baseline results and for the probabilistic sensitivity analyses
took much less time for the DES model. CONCLUSIONS: DES
may be the more (time) efﬁcient model in situations where time to
event is essential such as patient ﬂows in an ICU.
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OBJECTIVES: To examine new methods of incorporating model
calibration into sensitivity analyses and the effect of calibration
choices on the robustness of model results and uncertainty of
model parameters. METHODS: Seventy-nine model transition
probabilities used to describe the natural history of cervical
cancer (CC) were calibrated to thirty published target epidemio-
logic data using Nelder-Mead optimization. Because factors such
as choice of objective function (goodness-of-ﬁt measure) and
initial simplex (starting point) may lead to different optimized
solutions, we tested the effect of these choices by performing
ﬁfteen calibrations using ﬁve different objective function weight-
ing schemes and three different initial simplexes. The objective
function was weighted mean percentage deviation calculated by
dividing the absolute value of the difference between model esti-
mate and target value by the target value. Deterministic sensitiv-
ity analyses (DSA) were performed by inserting each of the ﬁfteen
calibrated parameter sets into the model and assessing the results.
In probabilistic sensitivity analyses (PSA), we assigned an equal
probability of selection to each calibrated parameter set and
bootstrapped (sampled with replacement) the calibrated param-
eter sets, combining them with a conventional second-order
Monte Carlo simulation for other model parameters. Model
results were assessed using a cost per quality-adjusted life-year
(QALY) incremental cost-effectiveness ratio (ICER). RESULTS:
The coefﬁcient of variation of individual transition probabilities
across the ﬁfteen calibrated parameter sets ranged from 0.06%–
162%. In DSA, the ICER range produced by the calibrations was
$6,700–$27,100 per QALY. When bootstrapped calibrations
were included in the PSA, the ICER 95% credible interval was
[$6,400,$28,000] compared with [$1,100,$9,400] when using
only the best-ﬁtting calibration. CONCLUSIONS: Different cali-
bration methods can lead to different optimized parameter sets,
producing different model results. Model calibration should
therefore be incorporated into sensitivity analyses to fully assess
the effects of calibration methods on model results.
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OBJECTIVES: Cost-effectiveness models should always be
amendable to updating once new data become available.
However, no one optimal method of synthesizing data currently
exists.METHODS:We compared three different methods to pool
existing parameters of a model for a chronic disease with new
data: ﬁxed effects (FE) and random effects (RE) meta-analysis and
Bayesian updating (BU). These methods were applied to obtain
updated estimates of transition probabilities between stable
disease states and event probabilities. RESULTS: Homogeneity
between studies providing “old” and “new” information was
conﬁrmed using the Q-statistic. The three methods resulted in
different estimates of probabilities and their standard errors (SE).
The FE model produced the lowest means and SEs for the
event probabilities (moderate disease: 0.0496 (0.0028); severe
disease: 0.0698(0.0026); very severe disease: 0.0892(0.0044)) and
the probabilities of the event being severe (0.1009 (0.0194);
0.1032(0.0122); 0.1761(0.0206), respectively). It also produced
the lowest mean and SEs for transition probabilities. The RE
model resulted in the highest probabilities of getting an event: at
most 20% higher than FE in very severe disease. Furthermore, the
RE model resulted in the highest SEs. The SE of the probability of
getting an event was at most 276% higher than in the FE model.
The SE of the probability of the event being severe was at most
112% higher. The SE for the transition probabilities was at most
218% higher than in the FE model. BU resulted in the highest
probability of an event being severe: up to 20% higher than FE in
the case of moderate disease. BU resulted in the highest transition
probabilities: up to 29% higher than FE. CONCLUSIONS: As
shown, the choice of method can affect resulting model para-
meter updates considerably. This can affect estimates of cost-
effectiveness and the uncertainty around them.
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